About Index Trending news
Forbion Capital Partners

Forbion Capital Partners

Forbion Capital Partners

Forbion Capital Partners invests in Life Sciences and Biomedical Technology companies developing worldclass drugs and technologies, with a clear focus on product development. .


Contributors to this profile

Alexa global traffic share

24 Jul 2017
Venture capital (Series C)
CD-Venture, Arcus Ventures, NGN Capital, +4

citybizlist : Exosome Diagnostics Raises $30M Series C

07 Feb 2017

Prexton Therapeutics, participated by Ysios Capital, Series B financing round raises € 29 millions to advance its novel Parkinson’s therapeutic.es

05 Jan 2017
Venture capital (Series B)

NeRRE Therapeutics picks up Series B funds

PE Hub
06 Sep 2016
Venture capital (Series A)
Sunstone Capital, MP Healthcare Venture Management, NRW.BANK, +3

Rigontec Raises €15M in Third Closing of Series A Funding

15 Jun 2016
Venture capital (Series B)
EMBL Ventures, Forbion Capital Partners, Edmond de Rothschild Investment Partners, +2

Allecra Therapeutics Announces €22 Million Series B Financing

07 Jan 2016
Venture capital (Series B)
Tiger Management, Qiagen, Arcus Ventures, +4

Exosome Diagnostics Completes $60 Million Series B Financing

02 Sep 2015
Venture capital (Series B)
Tiger Management, CD-Venture, Arcus Ventures, +2

Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing

11 Mar 2014
Venture capital (Series B)
b-to-v Partners AG, Qiagen, Arcus Ventures, +2

Exosome Diagnostics raises USD 27m in Series B Financing Partners AG

25 Jul 2012
04 Feb 2011
Venture capital (Series B)
Advent Venture Partners, Auriga Partners, Crédit Agricole Private Equity, +5
11 May 2010
Venture capital (Series A)
12 Mar 2010
30 Mar 2009
Venture capital (Series F)
Crédit Agricole Private Equity, Scottish Equity Partners (SEP), New Science Ventures, +4